The relation of urinary estrogen metabolites with mammographic densities in premenopausal women

Cancer Epidemiology

Volumn 36, Issue 5, 2012, Pages e310-e316

  Maskarinec, Gertraud ^a   Heak, Sreang ^a   Morimoto, Yukiko ^a   Custer, Laurie ^a   Franke, Adrian A ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast cancer risk; Mammographic density; Premenopausal women; Urinary estrogen metabolites

Indexed keywords

AGLYCONE; CREATININE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; ISOFLAVONE; PROGESTERONE; TESTOSTERONE;

ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; URINALYSIS;

EID: 84865863359     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2012.03.014     Document Type: Article

References (33)

1. McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(6):1159-1169.
2. Noh J.J., Maskarinec G., Pagano I., Cheung L.W., Stanczyk F.Z. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 2006, 15(1):20-28.
3. Martin L.J., Minkin S., Boyd N.F. Hormone therapy, mammographic density, and breast cancer risk. Maturitas 2009, 64(1):20-26.
4. Greendale G.A., Palla S.L., Ursin G., Laughlin G.A., Crandall C., Pike M.C., et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the postmenopausal estrogen/progestin interventions mammographic density study. Am J Epidemiol 2005, 162(9):826-834.
5. Sprague B.L., Trentham-Dietz A., Gangnon R.E., Buist D.S., Burnside E.S., Bowles E.J., et al. Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer 2011, 2(1):62-72.
6. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996, 36:203-232.
7. Obi N., Vrieling A., Heinz J., Chang-Claude J. Estrogen metabolite ratio: is the 2-hydroxyestrone to 16alpha-hydroxyestrone ratio predictive for breast cancer?. Int J Womens Health 2011, 3:37-51.
8. Sprague B.L., Trentham-Dietz A., Gangnon R.E., Buist D.S., Burnside E.S., Bowles E.J., et al. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2001, 10(6):627-634.
9. Maskarinec G., Williams A.E., Rinaldi S., Kaaks R. Mammographic densities and urinary hormones in healthy women with different ethnic backgrounds. Hormonal carcinogenesis IV: proceedings of the fourth international symposium 2005, 277-286. Springer Science+Business Media, New York. J.J. Li, S. Li, J.R. Daling (Eds.).
10. Falk R.T., Fears T.R., Xu X., Hoover R.N., Pike M.C., Wu A.H., et al. Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev 2005, 14(1):221-226.
11. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 2005, 77(20):6646-6654.
12. Falk R.T., Xu X., Keefer L., Veenstra T.D., Ziegler R.G. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 2008, 17(12):3411-3418.
13. Franke A.A., Custer L.J., Morimoto Y., Nordt F.J., Maskarinec G. Analysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS. Anal Bioanal Chem 2011.
14. Maskarinec G., Takata Y., Franke A.A., Williams A.E., Murphy S.P. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 2004, 134(11):3089-3094.
15. Maskarinec G., Franke A.A., Williams A.E., Hebshi S., Oshiro C., Murphy S., et al. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004, 13(11):1736-1744.
16. Maskarinec G., Robbins C., Riola B., Kane-Sample L., Franke A., Murphy S. Three measures show high compliance in soy intervention among premenopausal women. J Am Diet Assoc 2003, 103(7):861-866.
17. Byng J.W., Boyd N.F., Fishell E., Jong R.A., Yaffe M.J. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638.
18. Eliassen A.H., Ziegler R.G., Rosner B., Veenstra T.D., Roman J.M., Xu X., et al. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009, 18(11):2860-2868.
19. Setchell K.D., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132(12):3577-3584.
20. Franke AA, Lai JF, Halm BM, et al. Equol production changes over time in postmenopausal women. J Nutr Biochem. 2011 Jul 18. [Epub ahead of print].
21. Franke A.A., Lai J.F., Morimoto Y., Maskarenic G. Equol production over time in pre-menopausal women. Br J Nutr 2011.
22. Pettersson A., Hankinson S.E., Willett W.C., Lagiou P., Trichopoulos D., Tamimi R.M. Nondense mammographic area and risk of breast cancer. Breast Cancer Res 2011, 13(5):R100.
23. Eliassen A.H., Spiegelman D., Xu X., Keefer L.K., Veenstra T.D., Barbieri R.L., et al. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 2012, 72(3):696-706.
24. Maskarinec G., Nagata C., Shimizu H., Kashiki Y. Comparison of mammographic densities and their determinants in women from Japan and Hawaii. Int J Cancer 2002, 102(1):29-33.
25. Ursin G., Ma H., Wu A.H., Bernstein L., Salane M., Parisky Y.R., et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003, 12(4):332-338.
26. Trichopoulos D., Yen S., Brown J., Cole P., MacMahon B. The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA. Cancer 1984, 53(1):187-192.
27. Shimizu H., Ross R.K., Bernstein L., Pike M., Henderson B.E. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 1990, 62:451-453.
28. Iwasaki M., Kasuga Y., Yokoyama S., Onuma H., Nishimura H., Kusama R., et al. Comparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians. BMC Med 2011, 9:16.
29. Yong M., Schwartz S.M., Atkinson C., Makar K.W., Thomas S.S., Stanczyk F.Z., et al. Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States. J Steroid Biochem Mol Biol 2011, 124(12):10-18.
30. Yong M., Schwartz S.M., Atkinson C., Makar K.W., Thomas S.S., Newton K.M., et al. Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States. Cancer Epidemiol Biomarkers Prev 2010, 19(2):537-546.
31. Setiawan V.W., Haiman C.A., Stanczyk F.Z., Le M.L., Henderson B.E. Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2006, 15(10):1849-1855.
32. Pike M.C., Kolonel L.N., Henderson B.E., Wilkens L.R., Hankin J.H., Feigelson H.S., et al. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 2002, 11(9):795-800.
33. Im A., Vogel V.G., Ahrendt G., Lloyd S., Ragin C., Garte S., et al. Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis 2009, 30(9):1532-1535.